ETHSX: Eaton Vance Worldwide Health Sciences Fund - MutualFunds.com

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

Eaton Vance Worldwide Health Sci A

ETHSX - Snapshot

Vitals

  • YTD Return 9.0%
  • 3 Yr Annualized Return 11.3%
  • 5 Yr Annualized Return 7.0%
  • Net Assets $998 M
  • Holdings in Top 10 43.7%

52 WEEK LOW AND HIGH

$13.48
$9.26
$13.68

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.22%

SALES FEES

  • Front Load 5.75%
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 38.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) $1,000
  • IRA N/A

Fund Classification


Compare ETHSX to Popular Health Care Sector Equity Funds and ETFs

Overview

Income Profile

Income Risk

Returns Profile

Allocations

Expenses

About

$222.49

-0.11%

$46.04 B

1.11%

$2.43

6.86%

-

$109.74

+0.27%

$22.44 B

1.52%

$1.65

8.64%

-

$101.23

+0.70%

$15.09 B

0.05%

$0.05

24.32%

-

$107.87

+0.39%

$12.74 B

1.19%

$1.27

12.42%

-

$215.66

+0.31%

$12.74 B

1.20%

$2.55

13.29%

-

ETHSX - Profile

Distributions

  • YTD Total Return 9.0%
  • 3 Yr Annualized Total Return 9.2%
  • 5 Yr Annualized Total Return 5.7%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 0.50%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    Eaton Vance Worldwide Health Sciences Fund
  • Fund Family Name
    Eaton Vance
  • Inception Date
    Jul 26, 1985
  • Shares Outstanding
    56249502
  • Share Class
    A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Jason Kritzer

Fund Description

The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies principally engaged in the discovery, development, production or distribution of products related to scientific advances in health care, including biotechnology, pharmaceuticals, diagnostics, managed health care and medical equipment and supplies. It has a policy of investing at least 25% of its assets in investments in the medical research and health care industry.


ETHSX - Performance

Return Ranking - Trailing

Period ETHSX Return Category Return Low Category Return High Rank in Category (%)
YTD 9.0% -4.9% 137.5% 78.88%
1 Yr 10.4% -1.4% 132.6% 88.75%
3 Yr 11.3%* 0.8% 40.7% 46.85%
5 Yr 7.0%* -0.7% 29.6% 66.43%
10 Yr 12.5%* 8.1% 19.7% 78.05%

* Annualized

Return Ranking - Calendar

Period ETHSX Return Category Return Low Category Return High Rank in Category (%)
2019 19.3% 3.8% 63.8% 64.14%
2018 0.8% -49.7% 21.5% 15.33%
2017 13.1% -59.8% 54.4% 67.41%
2016 -24.6% -36.6% 11.6% 92.25%
2015 -1.4% -62.4% 27.9% 53.28%

Total Return Ranking - Trailing

Period ETHSX Return Category Return Low Category Return High Rank in Category (%)
YTD 9.0% -4.9% 137.5% 78.88%
1 Yr 4.0% -6.5% 132.6% 94.38%
3 Yr 9.2%* -0.3% 40.7% 71.33%
5 Yr 5.7%* -0.7% 29.6% 77.14%
10 Yr 11.8%* 8.1% 19.7% 86.18%

* Annualized

Total Return Ranking - Calendar

Period ETHSX Return Category Return Low Category Return High Rank in Category (%)
2019 19.3% 3.8% 63.8% 64.14%
2018 0.8% -25.3% 22.2% 21.90%
2017 16.2% -10.8% 54.4% 68.15%
2016 -14.8% -36.6% 11.6% 60.47%
2015 8.6% -16.6% 27.9% 27.05%

NAV & Total Return History


ETHSX - Holdings

Concentration Analysis

ETHSX Category Low Category High ETHSX % Rank
Net Assets 998 M 3.74 M 46 B 48.84%
Number of Holdings 61 24 426 76.74%
Net Assets in Top 10 460 M 952 K 19.6 B 48.84%
Weighting of Top 10 43.74% 14.0% 75.7% 35.47%

Top 10 Holdings

  1. Johnson & Johnson 7.12%
  2. UnitedHealth Group Inc 5.11%
  3. Roche Holding AG Dividend Right Cert. 4.69%
  4. Merck & Co Inc 4.38%
  5. Abbott Laboratories 4.11%
  6. Novartis AG 4.05%
  7. Novartis AG 4.05%
  8. Novartis AG 4.05%
  9. Novartis AG 4.05%
  10. Novartis AG 4.05%

Asset Allocation

Weighting Return Low Return High ETHSX % Rank
Stocks
99.99% 61.47% 102.50% 12.21%
Preferred Stocks
0.00% 0.00% 6.63% 17.44%
Other
0.00% -2.50% 6.07% 32.56%
Convertible Bonds
0.00% 0.00% 0.06% 2.91%
Cash
0.00% -0.01% 32.46% 87.21%
Bonds
0.00% 0.00% 16.11% 5.23%

Stock Sector Breakdown

Weighting Return Low Return High ETHSX % Rank
Healthcare
100.00% 61.81% 100.00% 1.74%
Utilities
0.00% 0.00% 0.00% 1.74%
Technology
0.00% 0.00% 15.86% 15.70%
Real Estate
0.00% 0.00% 6.03% 7.56%
Industrials
0.00% 0.00% 5.94% 11.05%
Financial Services
0.00% 0.00% 3.31% 38.37%
Energy
0.00% 0.00% 0.00% 1.74%
Communication Services
0.00% 0.00% 4.69% 5.23%
Consumer Defense
0.00% 0.00% 34.31% 8.72%
Consumer Cyclical
0.00% 0.00% 1.09% 9.30%
Basic Materials
0.00% 0.00% 2.60% 31.40%

Stock Geographic Breakdown

Weighting Return Low Return High ETHSX % Rank
US
69.56% 47.91% 99.98% 89.53%
Non US
30.43% 0.00% 43.79% 8.14%

ETHSX - Expenses

Operational Fees

ETHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.22% 0.08% 25.14% 40.96%
Management Fee 0.72% 0.00% 1.25% 59.30%
12b-1 Fee 0.25% 0.00% 1.00% 20.00%
Administrative Fee 0.15% 0.03% 0.40% 55.00%

Sales Fees

ETHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load 5.75% 3.50% 5.75% 4.35%
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

ETHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

ETHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 38.00% 0.70% 252.00% 55.21%

ETHSX - Distributions

Dividend Yield Analysis

ETHSX Category Low Category High ETHSX % Rank
Dividend Yield 0.00% 0.00% 3.15% 16.86%

Dividend Distribution Analysis

ETHSX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Annually Annually

Net Income Ratio Analysis

ETHSX Category Low Category High ETHSX % Rank
Net Income Ratio 0.50% -2.53% 2.53% 21.56%

Capital Gain Distribution Analysis

ETHSX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually Annually

Dividend Payout History

View More +

ETHSX - Fund Manager Analysis

Managers

Jason Kritzer


Start Date

Tenure

Tenure Rank

Jul 01, 2016

4.34

4.3%

Mr. Kritzer is a Vice President of Eaton Vance. Prior to joining Eaton Vance in 2012, Mr. Kritzer was a director and equity analyst at BlackRock , Inc. covering the healthcare sector since 2006.

Samantha Pandolfi


Start Date

Tenure

Tenure Rank

Jul 01, 2016

4.34

4.3%

Ms. Pandolfi is a Vice President of EVAIL. Prior to joining EVAIL, Ms. Pandolfi held similar positions at EVMI. Prior to joining EVMI as a Vice President in November 2015, Ms. Pandolfi was a Portfolio Manager and Research Analyst with Goldman Sachs Asset Management over her fifteen year tenure (2000-2015).

Tenure Analysis

Category Low Category High Category Average Category Mode
0.09 23.14 7.28 20.52
Continue to site >
Trending ETFs